Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04455503
Title Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Evaxion Biotech A/S
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.